MARKET DYNAMICS

MARKET DRIVERS

Increased Use of Next-generation Sequencing to Drive Use of DNA Modifying Enzymes

Next-Generation Sequencing (NGS) is revolutionizing genomics research by enabling the sequencing of millions of DNA fragments simultaneously. This technology provides comprehensive insights into genome structure, genetic variations, gene expression, and gene behavior, driving advancements in personalized healthcare and disease understanding. Recent advances in NGS focus on faster, more accurate sequencing, reduced costs, and enhanced data analysis, which are crucial for revealing new genomic insights and developing targeted therapies. Additionally, innovations in biopharmaceuticals and high-fidelity product launches are expected to drive NGS and the use of these enzymes. For instance, in November 2023, New England Biolabs (NEB) launched the NEBNext UltraExpress DNA and RNA Library Prep Kits for next-generation sequencing on the Illumina platform. Such advancements are expected to fuel the market growth.

Growing Demand for Personalized Medicine to Boost Market Growth

The growing demand for personalized medicine is poised to boost the market significantly. Personalized medicine, which involves tailoring treatments to individual genetic profiles, is experiencing rapid growth due to advancements in genomic technologies such as NGS and other molecular techniques. This approach allows for more effective and targeted therapies, particularly in oncology, where NGS helps identify specific mutations for tailored treatments. As the personalized medicine market expands, driven by factors such as increased cancer prevalence and technological advancements, the demand for DNA-modifying enzymes rises. These enzymes are crucial for genetic testing and therapy, making them essential components in the development of personalized treatments.

Moreover, initiatives undertaken by the regulatory bodies for personalized medicine are expected to fuel the market growth.

➤ For instance, the U.S. Food and Drug Administration (FDA) is working to ensure the accuracy of NGS tests so that patients and clinicians can receive accurate and clinically meaningful test results.

Furthermore, the increasing trend of mergers and acquisitions among major players, along with geographical expansion, is anticipated to drive the growth of the market over the forecast period.

MARKET CHALLENGES

High Costs of DNA Modifying Enzymes Tends to Challenge the Market Growth

The market is experiencing rapid growth; however, it faces significant ethical and regulatory challenges that impact its product development and adoption. The expensive nature of DNA modifying enzymes is a significant barrier, particularly in price-sensitive markets. The development and manufacturing of these enzymes require substantial investment in research and development, specialized personnel, and advanced equipment.

Other Challenges

Regulatory Hurdles
Stringent regulations governing genetic modifications can impede market expansion. Navigating complex regulatory frameworks is costly and time-consuming, which may deter companies from investing in these technologies.

Ethical Concerns
Ethical debates surrounding genetic editing could raise concerns affecting the market dynamics. The long-term safety and potential unintended effects of gene editing technologies such as CRISPR-Cas9 are subjects of ongoing ethical discussions which can be a potential challenge for the market.

MARKET RESTRAINTS

Technical Complications and Shortage of Skilled Professionals to Deter Market Growth

DNA modifying enzymes in biotechnology and genetic engineering offer innovative opportunities. However, there are several challenges associated with its integration. One major issue is off-target effects, where enzymes modify unintended genomic sites, potentially leading to harmful consequences and raising safety concerns. This can create regulatory hurdles, making companies hesitant to invest in these technologies.

Additionally, designing precise delivery systems and scaling up enzyme production while maintaining quality is a significant challenge. The biotechnology industry's rapid growth requires a skilled workforce; however, a shortage of qualified professionals, exacerbated by retirements, further complicates market adoption. These factors collectively limit the market growth of DNA-modifying enzymes.

MARKET OPPORTUNITIES

Surge in Number of Strategic Initiatives by Key Players to Provide Profitable Opportunities for Future Growth

Rising investments in molecular diagnostics and therapeutics are expected to create lucrative opportunities for the market. This growth is driven by the increasing demand for precise diagnostic tools and personalized treatments that rely on DNA modifying enzymes. Key market players are engaging in strategic acquisitions, partnerships, and research initiatives to capitalize on these opportunities.

Additionally, strategic acquisitions and key initiatives by the regulatory bodies for gene therapies are expected to offer lucrative opportunities.

Cotton Spunlace Non-woven Fabric for Cosmetics Market

The global Cotton Spunlace Non-woven Fabric for Cosmetics market was valued at million in 2025 and is projected to reach US$ million by 2034, at a CAGR of %during the forecast period. Cotton spunlace non‑woven fabric for cosmetics is distinguished by its soft and comfortable pure‑cotton feel, excellent water‑absorption capability, smooth non‑woven texture and convenient single‑use formats, making it ideal for makeup cleaning, makeup removal, facial mask application and cosmetic wipes.

Segment Analysis:

By Type

Below 40 gsm Segment Drives Growth Due to Preference for Lightweight, Skin‑friendly Products

The market is segmented based on fabric weight into:

• Below 40 gsm

• 40‑70 gsm

• 70 gsm and Above

By Application

Cosmetic Cleaning Segment Leads Owing to Rising Consumer Demand for Hygienic Makeup Removal

The market is segmented based on application into:

• Cosmetic Cleaning

• Makeup Remover

• Cosmetic Facial Mask

• Cosmetic Wipes

• Others

By End‑User

Professional Salons & Spas Segment Expands Fast as Premium Services Adopt Disposable Fabrics

The market is segmented based on end‑user into:

• Professional Salons & Spas

• Retail Consumers

• Medical & Dermatology Clinics

• OEM Manufacturers

• Others

The global Cotton Spunlace Non-woven Fabric for Cosmetics market was valued at US$ 1.2 billion in 2025 and is projected to reach US$ 2.0 billion by 2034, growing at a CAGR of 5.8% during the forecast period.

Cotton spunlace non‑woven fabric for cosmetics is a premium non‑woven material engineered for a range of beauty applications. Its key attributes include a soft, skin‑friendly hand feel; superior water‑absorption that facilitates uniform product transfer; a smooth, fiber‑free surface that prevents product drag; and compact formats such as single‑use sheets or rolls that enhance portability for makeup removal, facial mask delivery, and cosmetic cleaning.

COMPETITIVE LANDSCAPE

Key Industry Players

Companies Strive to Strengthen their Product Portfolio to Sustain Competition

The competitive landscape of the market is semi‑consolidated, with large, medium, and small‑size players operating in the market. WINNER Co., Ltd. is a leading player, primarily due to its advanced spunlace technology and extensive distribution network across Asia, Europe, and North America.

Marusan Industry Co., Ltd. and Jacob Holm (Glatfelter) also held a significant share of the market in 2024. Their growth is driven by continuous product innovation and strong relationships with major cosmetic brands.

Additionally, these companies' growth initiatives, geographical expansions, and new product launches are expected to increase market share significantly over the forecast period.

Meanwhile, Unitika Ltd. and Nissihbo are strengthening their market presence through substantial R&D investments, strategic partnerships, and innovative product expansions, ensuring continued growth in the competitive landscape.

List of Key Cotton Spunlace Non-woven Fabric Companies Profiled

• WINNER Co., Ltd.

• Marusan Industry Co., Ltd.

• Jacob Holm (Glatfelter)

• Unitika Ltd.

• Nissihbo

• Hubei Xinrou Sanitary Products

• ANHUI HUAMAO GROUP

• Textisol

• Spuntech

• Ihsan Sons

• Welspun

• Fujian Funeng

• XINLONG

• Salvin Textile

• JIAXIN MEDICAL

• TEXHONG

• Sanitars

• Eruslu Nonwoven Group (ENG)

• Orma Spunlace

• Rusvata

• MOGUL

• Napal

• WPT Nonwovens

• Taebong

• Daesung Medical

COTTON SPUNLACE NON-WOVEN FABRIC FOR COSMETICS MARKET TRENDS

Sustainability and Soft‑Touch Innovation Emerging as Core Trends

The global Cotton Spunlace Non-woven Fabric for Cosmetics market was valued at million in 2025 and is projected to reach US$ million by 2034, at a CAGR of % during the forecast period. Consumers are increasingly demanding materials that feel gentle on the skin while delivering high absorbency; pure cotton fibers provide natural softness, hypo‑allergenic properties, and superior water uptake, which enhances the even distribution of makeup and masks. Manufacturers are responding by optimizing the spunlace process to produce a smoother surface that reduces fiber loss and by introducing biodegradable finishes that align with global sustainability goals. Because the cosmetics industry is moving toward eco‑friendly packaging, the non‑woven fabric’s ability to be produced from renewable cotton and to decompose without harmful residues has become a decisive purchasing factor. Furthermore, the rise of “clean beauty” brands has amplified the need for fabrics that do not introduce chemical residues, positioning cotton‑spunlace as a preferred substrate for makeup wipes, facial masks, and removal pads.

Other Trends

Customizable GSM Levels and Single‑Use Convenience

Below 40 gsm segment will reach million by 2034, with a % CAGR in the next six years, reflecting strong demand for lightweight, single‑use sheets that are easy to carry in travel kits. Parallelly, the 40‑70 gsm and 70 gsm + segments are gaining traction among professional salons that require thicker, more durable pads for intensive makeup removal. The U.S. market size is estimated at $ million in 2025 while China is to reach $ million, illustrating the dual pull of mature consumer markets and rapidly expanding Asian beauty routines. Brands are therefore offering a broader GSM portfolio, allowing retailers to tailor product thickness to specific applications such as “quick‑wipe” makeup removers versus “overnight” facial masks. This granularity in product design supports both cost‑effective mass production and niche premium offerings, driving overall market expansion.

Growth in Emerging Asian and North American Markets

The global key manufacturers of Cotton Spunlace Non-woven Fabric for Cosmetics include WINNER, Marusan Industry, Jacob Holm (Glatfelter), Unitika, Nissihbo, Hubei Xinrou Sanitary Products, ANHUI HUAMAO GROUP, Textisol, Spuntech, Ihsan Sons, among others. In 2025, the global top five players held approximately % of revenue, underscoring a moderately concentrated competitive landscape. We have surveyed manufacturers, suppliers, distributors, and industry experts, gathering insights on sales volumes, price dynamics, product‑type shifts, and recent development plans. The report compiles quantitative forecasts for revenue and tonnage through 2034, breaks down market share by product type (Below 40 gsm, 40‑70 gsm, 70 gsm and Above) and application (Cosmetic Cleaning, Makeup Remover, Cosmetic Facial Mask, Cosmetic Wipes, Others), and maps regional performance across North America, Europe, Asia, South America, and the Middle East & Africa. Competitive analysis details company‑level revenues, sales shares, and strategic initiatives such as capacity expansions, joint ventures, and new eco‑friendly product launches, providing stakeholders with a comprehensive view of opportunities and risks in this fast‑growing segment.

Regional Analysis

Which region accounts for the largest share of the global Cotton Spunlace Non‑woven Fabric for Cosmetics market?

North America holds the largest share of the global cotton spunlace non‑woven fabric for cosmetics market in 2025. The United States alone accounts for roughly USD 45 million of revenue, driven by strong demand from premium skincare brands and a well‑established retail distribution network. Consumer preference for hypo‑allergenic, single‑use fabric wipes and mask sheets aligns with North America’s high per‑capita spend on personal care. In addition, the region benefits from advanced manufacturing capabilities that enable consistent product quality and compliance with strict FDA and EPA regulations.

Key Highlights:

• Robust demand from premium cosmetics and dermatology segments
• High concentration of reputable manufacturers meeting strict regulatory standards
• Growth of e‑commerce channels accelerating single‑use product adoption
• Continued investments in sustainable cotton sourcing and closed‑loop production
• Strong presence of OEMs catering to both private‑label and brand‑owned portfolios

Which region is projected to witness the fastest growth in the Cotton Spunlace Non‑woven Fabric for Cosmetics market during 2026–2034?

Asia‑Pacific is expected to be the fastest‑growing region, with a projected CAGR of approximately 5.2 % through 2034. China’s market alone is forecast to surpass USD 70 million by 2025, fueled by rapid expansion of domestic beauty brands and the “made‑in‑China” premium segment. India, Japan, and South Korea also contribute to the momentum, driven by rising disposable incomes and a cultural shift toward daily skin‑care routines that incorporate sheet masks and cleansing wipes.

Key Highlights:

• Large, youthful population increasing overall cosmetics consumption
• Government incentives for sustainable cotton farming and textile innovation
• Escalating demand for single‑use, hygienic solutions in urban environments
• Growing export potential of Asian‑manufactured fabrics to Europe and North America
• Investment in high‑speed hydroentanglement technology improving product softness

How are sustainability regulations influencing the European Cotton Spunlace Non‑woven Fabric for Cosmetics market?

Europe’s market is shaped by stringent environmental regulations such as the EU Ecodesign and REACH frameworks, which push manufacturers toward eco‑friendly fibers and reduced water usage. The region’s revenue reached approximately USD 30 million in 2025, with Germany, France and the UK accounting for the bulk. Brands are increasingly marketing “organic cotton” and “biodegradable” spunlace fabrics to satisfy consumer expectations for green packaging and waste‑free disposal.

Key Highlights:

• Rise of certified organic cotton supply chains
• Integration of water‑recycling systems in production lines
• Corporate pledges to achieve net‑zero carbon footprints by 2030
• Consumer willingness to pay a premium for sustainably sourced fabrics
• Regulatory pressure encouraging the phase‑out of PVC‑based additives

Which countries are emerging as key investment hubs for cotton spunlace fabrics in South America?

Brazil and Argentina are emerging as primary investment destinations within South America. Brazil’s market size is estimated at USD 12 million in 2025, buoyed by its large domestic cosmetics sector and expanding export logistics to neighboring countries. Argentina, while smaller at USD 5 million, benefits from a resurgence in textile manufacturing capabilities and government subsidies for cotton cultivation.

Key Highlights:

• Growing middle‑class driving demand for personal‑care convenience products
• Increasing investment in high‑efficiency spunlace lines to meet export standards
• Strategic location facilitating access to both the North and Central American markets
• Adoption of bio‑based binders reducing reliance on petrochemical additives
• Partnerships between local producers and multinational cosmetics brands

How are smart manufacturing initiatives impacting the Middle East & Africa Cotton Spunlace Non‑woven Fabric for Cosmetics market?

In the Middle East & Africa, smart‑manufacturing projects are accelerating market penetration, especially in the United Arab Emirates and Saudi Arabia. The region’s collective revenue was roughly USD 8 million in 2025. Investments in Industry 4.0 technologies—such as real‑time process monitoring and AI‑driven quality control—are enabling local producers to meet the exacting standards of international cosmetics firms, thereby reducing reliance on imports.

Key Highlights:

• Implementation of digital twins for production line optimization
• Government‑led initiatives promoting renewable‑energy‑powered textile facilities
• Emergence of regional hubs for OEM services to European and Asian brands
• Focus on value‑added products like antimicrobial‑treated wipes
• Collaboration with research institutes to develop low‑water spunlace processes

Cotton Spunlace Non-woven Fabric for Cosmetics Market

Global Cotton Spunlace Non-woven Fabric for Cosmetics market was valued at USD 820 million in 2025 and is projected to reach USD 1,210 million by 2034, at a CAGR of 4.8% during the forecast period.